Literature DB >> 1426022

3-(2-Carboxypiperazin-4-yl)propyl-1-phosphonic acid decreases NMDA receptor mRNA.

K P Lesch1, C S Aulakh, B L Wolozin, J L Hill, D L Murphy.   

Abstract

Expression of the N-methyl-D-aspartate receptor gene during long-term administration of competitive and non-competitive NMDA antagonists was studied in rat brain using antisense cRNA transcribed from reverse transcriptase-polymerase chain reaction (RT-PCR)-generated rat NMDA receptor cDNA. Unlike non-competitive antagonists, 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) markedly decreased NMDA receptor mRNA steady-state concentrations in frontal cortex and hippocampus. Our results are consistent with a regulation of the NMDA receptor at the level of gene expression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1426022     DOI: 10.1016/0922-4106(92)90151-k

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Modulation of dopamine D2 receptor expression by an NMDA receptor antagonist in rat brain.

Authors:  V D Nair; J E Savelli; R K Mishra
Journal:  J Mol Neurosci       Date:  1998-10       Impact factor: 3.444

Review 2.  Selected β2-, β3- and β2,3-Amino Acid Heterocyclic Derivatives and Their Biological Perspective.

Authors:  Urszula Bąchor; Marcin Mączyński
Journal:  Molecules       Date:  2021-01-15       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.